J
J. D. A. Van Embden
Researcher at Complutense University of Madrid
Publications - 60
Citations - 13726
J. D. A. Van Embden is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Mycobacterium tuberculosis & Restriction fragment length polymorphism. The author has an hindex of 41, co-authored 60 publications receiving 13412 citations.
Papers
More filters
Journal ArticleDOI
Overproduction and purification of Treponema pallidum recombinant-DNA-derived proteins TmpA and TmpB and their potential use in serodiagnosis of syphilis.
TL;DR: TmpB is not suitable for serodiagnostic purposes as a single antigen, because a significant fraction of sera from syphilitic patients was nonreactive with TmpB, and a correlation was found between the presence of anti-TmpA antibodies and anti-cardiolipin antibodies.
Journal ArticleDOI
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis.
D. van Soolingen,P. E. W. De Haas,Robert Blumenthal,Kristin Kremer,M. Sluijter,J. E. M. Pijnenburg,Leo M. Schouls,J. E. R. Thole,M. Dessens-Kroon,J. D. A. Van Embden,Peter W. M. Hermans +10 more
TL;DR: The basis for an apparent dichotomy in PvuII restriction fragment pattersn observed among strains of the M. tuberculosis complex is investigated and site-directed mutagenesis analysis revealed that this sequence was a target for modification.
Journal ArticleDOI
A new beta-lactamase plasmid in Neisseria gonorrhoeae.
Journal ArticleDOI
Decrease of Drug Resistance in Salmonella in The Netherlands
W. J. van Leeuwen,J. D. A. Van Embden,P. A. M. Guinée,E. H. Kampelmacher,A. Manten,M. van Schothorst,C. E. Voogd +6 more
TL;DR: Since 1974, tetracycline resistance in salmonellae of human and porcine origin has decreased nation-wide in The Netherlands, and this decrease has coincided with the ban on incorporation of tetrACYcline in animal feeds.
Journal ArticleDOI
Murine peritoneal macrophages activated by the mycobacterial 65-kilodalton heat shock protein express enhanced microbicidal activity in vitro.
W. E. Peetermans,J. A. M. Langermans,M. E. B. Van Der Hulst,J. D. A. Van Embden,R. Van Furth +4 more
TL;DR: The adjuvant dimethyl dioctadecylammonium bromide (DDA) was preferred because it contains no endotoxin or mycobacterial antigens and because it has been reported that DDA does not induce the production of gamma interferon.